ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?

Show other versions (1)

The role of beta-blockers (BB) in arterial hypertension therapy is discussed from the evidence based medicine point of view and according to international guidelines. Data of the latest meta-analysis comparing effects of BB and other antihypertensive drugs on a probability of cardio-vascular complic...

Full description

Bibliographic Details
Main Author:	S. Y. Martsevich
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	arterial hypertension beta-adrenoblockers evidence based medicine
Online Access:	https://www.rpcardio.online/jour/article/view/603

Similar Items

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01)

Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
by: S A Belyaeva, et al.
Published: (2011-04-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
by: L. L. Kirichenko, et al.
Published: (2006-12-01)

BETA-ADRENOBLOCKERS IN LONG-TERM MONOTHERAPY AMONG PATIENTS WITH ARTERIAL HYPERTENSION: EFFECTS ON QUALITY OF LIFE AND TREATMENT COMPLIANCE
by: F. Z. Kasumova
Published: (2010-10-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Beta-adrenoblockers in cardiology practice
by: A. A. Garganeeva
Published: (2010-10-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved?
by: Yu. M. Lopatin
Published: (2009-12-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

BETA-ADRENOBLOCKER THERAPY IN ARTERIAL HYPERTENSION, METABOLIC DISTURBANCES, AND TYPE 2 DIABETES MELLITUS
by: D. V. Nebieridze, et al.
Published: (2009-08-01)

ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01)

Evaluation methods of α and β2-adrenoreactivity of human erythrocytes to change their osmotic resistance under the effect of adrenaline and adrenoblockers
by: F. O. Voloh
Published: (2017-01-01)

Evaluation methods of α and β2-adrenoreactivity of human erythrocytes to change their osmotic resistance under the effect of adrenaline and adrenoblockers
by: F. O. Voloh
Published: (2017-01-01)

Platelet aggregation activity and beta-adrenoblocker therapy in patients with dilated cardiomyopathy
by: P. N. Isakhanova, et al.
Published: (2012-02-01)

Current guidelines for β-adrenoblockers use in cardiovascular diseases: focus on metoprolol succinate CR/XL: A review
by: Marina G. Bubnova
Published: (2022-07-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension
by: E В Mazo, et al.
Published: (2004-03-01)

Experience with the successful use of topical beta-adrenoblockers in the treatment of infantile hemangiomas: a clinical case and review of the literature
by: R. V. Saranyuk, et al.
Published: (2024-05-01)

EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE
by: S. A. Smakotina, et al.
Published: (2016-01-01)

Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
by: N. G. Pivonova, et al.
Published: (2009-08-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

DIURETIC-BASED COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION: RESULTS OF THE RUSSIAN TRUST STUDY
by: N. E. Gavrilova, et al.
Published: (2013-08-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Beta-adrenoblockers use in combination of cardiovascular and pulmonary diseases
by: V I Makolkin, et al.
Published: (2008-08-01)

Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
by: D. V. Duplyakov
Published: (2009-08-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Myocardial infarction in elderly patients.Role of beta-adrenoblockers in its treatment and secondaryprevention
by: I A Komissarenko
Published: (2003-11-01)

CARDIO-SELECTIVE BETA-ADRENOBLOCKER SAFETY IN CARDIOVASCULAR DISEASE TREATMENT AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: B. V. Trapeznikova, et al.
Published: (2010-06-01)